Matthews VB - Search Results

1

Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2.

Matthews VB, Elliot RH, Rudnicka C, Hricova J, Herat L, Schlaich MP. Matthews VB, et al. J Hypertens. 2017 Oct;35(10):2059-2068. doi: 10.1097/HJH.0000000000001434. J Hypertens. 2017. PMID: 28598954

2

Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice.

Lindegaard B, Matthews VB, Brandt C, Hojman P, Allen TL, Estevez E, Watt MJ, Bruce CR, Mortensen OH, Syberg S, Rudnicka C, Abildgaard J, Pilegaard H, Hidalgo J, Ditlevsen S, Alsted TJ, Madsen AN, Pedersen BK, Febbraio MA. Lindegaard B, et al. Among authors: matthews vb. Diabetes. 2013 Sep;62(9):3064-74. doi: 10.2337/db12-1095. Epub 2013 May 13. Diabetes. 2013. PMID: 23670974 Free PMC article.

3

Is it time to think about the sodium glucose co-transporter 2 sympathetically?

Elliott RH, Matthews VB, Rudnicka C, Schlaich MP. Elliott RH, et al. Among authors: matthews vb. Nephrology (Carlton). 2016 Apr;21(4):286-94. doi: 10.1111/nep.12620. Nephrology (Carlton). 2016. PMID: 26369359 Review.

4

Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.

Hoyne G, Rudnicka C, Sang QX, Roycik M, Howarth S, Leedman P, Schlaich M, Candy P, Matthews V. Hoyne G, et al. BMC Cancer. 2016 Feb 24;16:151. doi: 10.1186/s12885-016-2178-4. BMC Cancer. 2016. PMID: 26912236 Free PMC article.

5

Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer.

Rudnicka C, Mochizuki S, Okada Y, McLaughlin C, Leedman PJ, Stuart L, Epis M, Hoyne G, Boulos S, Johnson L, Schlaich M, Matthews V. Rudnicka C, et al. Medicine (Baltimore). 2016 Oct;95(40):e5085. doi: 10.1097/MD.0000000000005085. Medicine (Baltimore). 2016. PMID: 27749584 Free PMC article.

6

ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Weerasekera L, Rudnicka C, Sang QX, Curran JE, Johnson MP, Moses EK, Göring HH, Blangero J, Hricova J, Schlaich M, Matthews VB. Weerasekera L, et al. Among authors: matthews vb. Mediators Inflamm. 2017;2017:7281986. doi: 10.1155/2017/7281986. Epub 2017 Feb 7. Mediators Inflamm. 2017. PMID: 28265178 Free PMC article.

7

The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice.

Herat L, Rudnicka C, Okada Y, Mochizuki S, Schlaich M, Matthews V. Herat L, et al. Int J Mol Sci. 2017 Apr 21;18(4):884. doi: 10.3390/ijms18040884. Int J Mol Sci. 2017. PMID: 28430139 Free PMC article.

8

The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.

Carnagarin R, Gregory C, Azzam O, Hillis GS, Schultz C, Watts GF, Bell D, Matthews V, Schlaich MP. Carnagarin R, et al. Curr Hypertens Rep. 2017 Oct 28;19(12):99. doi: 10.1007/s11906-017-0795-1. Curr Hypertens Rep. 2017. PMID: 29080925 Free article. Review.

9

Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production.

Saunders BM, Rudnicka C, Filipovska A, Davies S, Ward N, Hricova J, Schlaich MP, Matthews VB. Saunders BM, et al. Among authors: matthews vb. Immunol Cell Biol. 2018 Jan;96(1):41-53. doi: 10.1111/imcb.1002. Epub 2017 Nov 23. Immunol Cell Biol. 2018. PMID: 29359470

10

Pharmacotherapeutic strategies for treating hypertension in patients with obesity.

Carnagarin R, Matthews V, Gregory C, Schlaich MP. Carnagarin R, et al. Expert Opin Pharmacother. 2018 May;19(7):643-651. doi: 10.1080/14656566.2018.1458092. Epub 2018 Mar 30. Expert Opin Pharmacother. 2018. PMID: 29600880 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters